AddLife AB (publ) Just Beat EPS By 8.9%: Here's What Analysts Think Will Happen Next

It's been a pretty great week for AddLife AB (publ) (STO:ALIF B) shareholders, with its shares surging 14% to kr174 in the week since its latest quarterly results. AddLife reported kr2.7b in revenue, roughly in line with analyst forecasts, although statutory earnings per share (EPS) of kr0.98 beat expectations, being 8.9% higher than what the analysts expected. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.

Our free stock report includes 1 warning sign investors should be aware of before investing in AddLife. Read for free now.

After the latest results, the two analysts covering AddLife are now predicting revenues of kr10.7b in 2025. If met, this would reflect a modest 2.3% improvement in revenue compared to the last 12 months. Per-share earnings are expected to jump 39% to kr3.53. In the lead-up to this report, the analysts had been modelling revenues of kr10.6b and earnings per share (EPS) of kr3.48 in 2025. The consensus analysts don't seem to have seen anything in these results that would have changed their view on the business, given there's been no major change to their estimates.

Check out our latest analysis for AddLife

It will come as no surprise then, to learn that the consensus price target is largely unchanged at kr179.

Of course, another way to look at these forecasts is to place them into context against the industry itself. We would highlight that AddLife's revenue growth is expected to slow, with the forecast 3.1% annualised growth rate until the end of 2025 being well below the historical 16% p.a. growth over the last five years. Compare this against other companies (with analyst forecasts) in the industry, which are in aggregate expected to see revenue growth of 7.4% annually. So it's pretty clear that, while revenue growth is expected to slow down, the wider industry is also expected to grow faster than AddLife.

The Bottom Line

The most important thing to take away is that there's been no major change in sentiment, with the analysts reconfirming that the business is performing in line with their previous earnings per share estimates. Fortunately, the analysts also reconfirmed their revenue estimates, suggesting that it's tracking in line with expectations. Although our data does suggest that AddLife's revenue is expected to perform worse than the wider industry. The consensus price target held steady at kr179, with the latest estimates not enough to have an impact on their price targets.

Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. At least one analyst has provided forecasts out to 2027, which can be seen for free on our platform here.

Before you take the next step you should know about the 1 warning sign for AddLife that we have uncovered.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.